|
Randi
and Paul Hagerman
Randi Jenssen Hagerman, MD is a developmental
and behavioral pediatrician and the Tsakopoulos-Vismara
professor of Pediatrics at the University of California
at Davis, Medical Center. Dr. Hagerman is the Director
of the MIND Institute (Medical Investigation of Neurodevelopment
Disorders) at UC Davis and has become internationally
known as a Fragile X clinician and researcher. As the
Director of the MIND Institute, Dr. Hagerman is at the
helm of one of the country's primary clinics for evaluation,
diagnosis and treatment of a wide spectrum of neurodevelopment
disorders including Autism, Asperger's and Fragile X.
Her husband, Paul, joined UC Davis in the Department of
Biological Chemistry and as an associate researcher with
the M.I.N.D. Institute.
A founding CFXF Scientific Advisor, Dr. Hagerman has been
quoted previously in this newsletter as having told the
U.S. Congress that "Fragile X is a 'research portal' for
other brain disorders. It is the leading-edge candidate
for a breakthrough in understanding many other diseases,
especially autism". This fact of Fragile X as a 'portal'
is most attractive to researchers such as Dr. Hagerman
who recognize its potential to unlock the mystery of disorders
that affect millions of people around the world. Dr. Hagerman
has spent over 20 years on Fragile clinical work and research,
particularly in molecular clinical correlation and treatment
endeavors. Dr. Hagerman is the chairman of the Scientific
and Clinical Advisory Committee of the National Fragile
X Foundation and is a scientific reviewer for the FRAXA
Foundation. The third edition of Dr. Hagerman's book,
Fragile X Syndrome: Diagnosis, Treatment and Research,
will be published in 2002 by the Johns Hopkins University
Press. |


|